CML is characterized by a chromosomal translocation between chromosomes 9 and 22, resulting in the formation of the BCR::ABL1 oncoprotein, which drives the uncontrolled proliferation of blood stem cells [4,5]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.